FRIDAY, Nov. 1 (HealthDay News) -- Bruce Cleland has vivid
memories of the day in 1986 when he learned that his daughter
Georgia, then 2, had been diagnosed with the most common form of
He got the news that Georgia had acute lymphoblastic leukemia in
a phone call from his wife, Izzi.
"I nearly fell out of my chair," Cleland recalled recently. "Leukemia was a really dark word. I thought it was a death sentence."
Although it's still a frightening diagnosis, the overall
five-year relative survival rate for this blood cancer has more
than quadrupled since 1960.
Clare Karten, senior director of patient engagement strategy at
the Leukemia & Lymphoma Society, said a significant amount of
medical progress has been made in the past 25 years.
"For everybody with every type of blood cancer, there is more hope than ever before," Karten said. "That's for sure."
Cleland can vouch for that. His daughter, now 29, is
cancer-free. The experience also prompted Cleland to create a new
way to raise money for research that has become a national model
and inspired millions: running for charity.
But the first two years after Georgia's diagnosis were tough,
"When something like this happens, you initially think the sky is falling on you," he said. "Then there is the resilience of human nature and you pick yourself up, reassess the situation, get educated, discover support groups and start to figure it out."
For the next two years, Cleland and his wife immersed themselves
in a new reality involving chemotherapy and radiation treatment for
the cancer that had spread to Georgia's brain. An entrepreneur,
Cleland also put his business acumen to work for a cause now close
to his heart.
He and his wife joined the board of the Westchester County,
N.Y., chapter of the Leukemia & Lymphoma Society. Cleland was
soon chosen to contribute to the organization's fundraising efforts
in support of groundbreaking research. After many traditional
fundraisers, Cleland knew it was time for a change.
At 41, Cleland was out of shape and looking for ways to get
outside. Always intrigued by the idea of running a marathon,
Cleland reached out to a friend, Olympic long-distance runner Rod
Dixon. With Dixon's help, Cleland made the decision to trade in his
tuxedo for running gear. Rather than dine and dance, he'd race for
Cleland devised a plan to form a team that would run in the 1988
New York City Marathon to raise money for leukemia research. He
managed to recruit a total of 38 unlikely marathon runners for his
team that first year. He didn't know it at the time, but he and his
team were making history as the first organized charity
Although Cleland expected corporate sponsors or individual
donors to give what they could, he admits now that many donations
came in as bets. "They'd say, 'I'll give you $10 a mile, but only
if you finish,'" he said. Using the training advice they'd received
from Dixon, each team member completed the marathon. Cleland
crossed the finish line in five hours and 23 minutes.
"I said our objective was to raise $150,000 because I thought it would help motivate people, but it was unheard of at the time for one event," Cleland said.
The first run raised $322,000.
Following the success of that first marathon, the Leukemia &
Lymphoma Society reached out to Cleland to learn exactly how he had
pulled it off. Based on his initial business plan, the organization
rolled out a national Team in Training program.
Since then, 600,000 participants involved in a variety of Team
in Training events, such as marathons, half marathons and
triathlons, have raised $1.4 billion for blood cancer research.
"It's kind of a mind-bending amount of money," Cleland said. "That's where the headline often ends, but the really important part is what's happened to that money."
The research grants provided by the Leukemia & Lymphoma
Society have funded many of the most innovative and promising
advances, including targeted therapies and immunotherapies.
"We create partnerships with universities, as well as biotechnology and pharmaceutical companies, to get treatments to patients, especially those with unmet medical needs," Karten said.
For Cleland, the journey has brought powerful personal
Georgia doesn't remember much about her cancer treatment. But
she said she'll never forget the undying support of her family.
Georgia also has completed three Team in Training half
marathons. When she signed up for her first race, she said her dad
"He said, 'Are you really going to do this?' I said, 'Just watch me!' "
Crossing her first finish line, Georgia said she saw her father
and shed tears of joy. "It was an amazing experience," she said.
"Every time I sign up for a [Team in Training] event it's just
beyond exciting. It's not just about me. I enjoy the opportunity to
meet participants who are helping to save even more lives and hear
Looking back, Cleland said quitting was never an option. "You
can never give up, no matter how bleak or tough it gets. The sun
will come up the next day and there will be a tomorrow," he said.
"It's just about how you are going to deal with it. What you do is
what will define you."
The Leukemia & Lymphoma Society's Information Resource
Center provides details on
treatments for leukemia and other forms of blood
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.